Skip to content

Assessment of Screening Coverage, Treatment Adherence, and Barriers to Care for Diabetes and Hypertension in an Urban Primary Health Centre Catchment Area in Bengaluru

Baseline and end line studies among vulnerable populations in selected UPHCs of Greater Bengaluru Authority (Formerly BBMP) to assess the effectiveness of an intervention on the reach of diabetes and hypertension screening services, lifestyle behaviors and treatment adherence among individuals diagnosed with diabetes and hypertension - Not Applicable

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107772
Enrollment
950
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

World Diabetes Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1: individuals residing in the vulnerable area and who are aged 30+ years neither with Diabetes or Hypertension. Group 2: individuals residing in the vulnerable area and who are aged 30+ with Diabetes or Hypertension Qualitative exploration will be conducted with the frontline workers, facility staff specially allied health staff, community structure

Exclusion criteria

Exclusion criteria: Group 1 : A person with is not able to participate due to severe morbidity or disability or adults aged below 30 and unwilling to consent Group 2 : A person with is not able to participate due to severe morbidity or disability or adults aged below 30 and unwilling to consent

Design outcomes

Primary

MeasureTime frame
Group 1 Increased uptake of screening and early diagnosis of Diabetes and Hypertension. Group 2 Increased adherence to treatment to achieve metabolic control, wherein individuals with Diabetes or Hypertension undergo regular follow-up testing once every three months to monitor and maintain optimal clinical parameters.Timepoint: 18 months

Secondary

MeasureTime frame
Group 1 The study will assess barriers to screening for diabetes & hypertension including awareness accessibility & utilization of UPHC services. It will evaluate patterns of health service utilization & levels of community engagement in NCD prevention. Feasibility of screening services at the community level will also be assessed. Group 2 The study will assess barriers to treatment adherence & lifestyle modification including access to care & followup services. It will evaluate health service utilization for ongoing management of diabetes & hypertension. Community engagement & the feasibility & acceptability of service delivery for NCD care will also be explored.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Swaroop

Karnataka Health Promotion Trust

swaroop.n@khpt.org7022035031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026